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Interaction of the novel agent amphethinile with tubulin
A.T. McGown & B.W. Fox
Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Wilmslow Road, Manchester M20 9BX,
UK.
Summary The novel agent amphethinile is shown to inhibit tubulin assembly in vitro. This agent is capable
of displacing colchicine but not vinblastine from tubulin and causes a stimulation in GTPase activity in vitro.
The affinity constant for the association of this drug with tubulin has been determined (Ka= 1.3 x 106 M-).
It is concluded that amphethinile belongs to the class of agents which share a common binding
site with colchicine on the tubulin molecule.
The novel synthetic agent amphethinile (2-amino-3-cyano-5-
(phenylthio)-indole, ICI 134154) is currently undergoing
clinical trials by members of the Cancer Research Campaign
Clinical Tri'als Group. This drug has been shown (McGown
et al., 1988) to result in a G2/M phase block in cell cycle
progression. This work describes the interaction of this agent
with purified tubulin, in order to determine whether
impairment of microtubular function is the mechanism by
which this agent exerts its anticancer action.
Amphethinile has been compared with known tubulin
binding agents (vinca alkaloids and colchicine) in order to
elucidate further its site of action on the tubulin protein.
Measurement of GTPase activity
The effect of amphethinile (1OpM) on the GTPase activity of
tubulin was measured following incubation of protein under
conditions described by Hamel and Lin (1982). The
incubation buffer (1 M glutamate, 1 mM GTP, pH6.6)
containing tubulin (1 mgml-1) was maintained at 37°C.
Aliquots were removed and analysed for GTP and GDP
content by HPLC analysis. Separation was achieved using
isocratic elution from a Nucleosil 5SB column (Technicol,
Stockport, UK) by potassium dihydrogen phosphate (1 M) at
1 mlmin- 1; detection was by absorption (A=254nm) and by
fluorescence (,,.=260nm, R,em=390nm). Retention times
were (typically) GTP 720 seconds and GDP 580 seconds.
Materials and methods
Drugs
Amphethinile was kindly donated by Imperial Chemical
Industries (Pharmaceutical Division). Radiolabelled drugs
(3H-vinblastine sulphate, 17Cimmol- 1 and 3H-colchicine
7.5Cimmol-1) were supplied by Amersham plc, UK.
Purification of tubulin
Microtubule protein was isolated from fresh bovine brain by
two cycles of assembly-disassembly according to the method
of Shelanski et al. (1973) as modified by Miglietta et al.
(1987). Purified protein (25mgml-1) was stored at -80°C in
a buffer solution containing 2-(N-morpholinoethansulphonic
acid) (MES) 0.1M, ethylenglycol-bis-(,B-amino-ethylether)-N,
N-tetra-acetic acid (EGTA) mM, MgCl2 0.5 mM, at pH6.6
(buffer A). Temperature-induced assembly-disassembly in
the presence of GTP was determined as a measure of
functionality for each tubulin sample removed from the
freezer. No decrease in functionality was noted for periods
of more than 4 months. The molecular weight of tubulin
monomer was taken as 50,000 (Valenzuela et al., 1981).
Protein was assayed by SDS-electrophoresis. Purity was
greater than 95%. No attempt was made to separate MAP
proteins from the tubulin.
Tubulin assembly
Tubulin assembly was measured turbidimetrically at 350nm
in a Beckman DU8 spectrophotometer with a six place
micro-cuvette (300p, per sample) equipped with rapid
electronic heating and cooling. Tubulin (2mgml-1) in Buffer
A was made 1 mM in GTP while maintained at 10°C. The
temperature was then raised rapidly to 35°C while the
absorption at 350nm was measured. Drugs were added to
the solution either before or after assembly. A control
solution containing no tubulin protein was monitored to
correct for temperature-induced absorption changes not
associated with tubulin assembly.
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Binding of 3H-colchicine and 3H-vinblastine in the presence
of amphethinile
Binding of radiolabelled drug to tubulin was measured by a
modification of the method of Borisy (1972) as described by
Hamel and Lin (1982). This utilises the strong affinity of
tubulin for DEAE-cellulose. Briefly tubulin (100l gml-1) in
buffer (1.0M glutamate, 0.1 M glucose 1-phosphate, 1 mM
GTP, and 0.5mgml-1 bovine serum albumin pH6.6) was
incubated in the dark for 1 h at 37°C with either 3H-
colchicine or 3H-vinblastine in the presence or absence of
amphethinile. Tubulin was then added to a stack of two
filters (Whatman DE81) and tubulin allowed to bind
(5min). The filters were then washed with buffer, dried and
counted uisng Ecoscint (National Diagnostics, New Jersey,
USA). All experiments were performed in quadruplicate.
Results are expressed as the percentage of control (3H-drug
only) binding. Control filters with no added tubulin (3H-
drug only) were counted on each occasion. Binding of
radiolabelled drug in the absence of tubulin was (typically)
6% of that when tubulin was present.
Tubulin fluorescence
The effect of amphethinile on tubulin fluorescence was
measured using a Shimadzu RF540 spectrofluorimeter.
Tubulin (100gM in buffer A) was mixed with increasing
concentrations of amphethinile, up to a molar ratio of 3
amphethinile/tubulin. The effect on native tubulin
fluorescence was monitored ('ex =275+2nm, Al{m=330+5nm)
following incubation of the drug with protein for 1 h at 37°C
in the dark. Results are expressed relative to fluorescence of
tubulin alone (100%).
An empirical correction for the quenching of tubulin
fluorescence by amphethinile was determined from standard
tryptophan solutions containing the drug, since this amino
acid is the principal fluorochrome in tubulin. All points
shown represent the mean of triplicate samples. The
association constant of amphethinile to tubulin was
calculated from the fluorescence data as described by
Prakash and Timasheff (1983).
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Results
The effect of amphethinile on tubulin assembly in vitro is
shown in Figure 1. It can be seen that amphethinile causes a
concentration-dependent decrease in tubulin assembly as
measured by turbidimetric methods as described in Materials
and methods. The concentration of amphethinile required to
cause a 50% decrease in tubulin assembly ( 12pM) is very
similar to that observed for colchicine (11 M) under
identical conditions. Amphethinile can be seen to have no
rapid disruptive effect when added to assembled micro-
tubules (Figure 2). This is again similar to colchicine.
The number of binding sites of amphethinile on tubulin
was determined using fluorescence quenching (Figure 3).
Amphethinile can be seen to quench tubulin fluorescence in
a concentration-dependent manner. The extent of
fluorescence quenching is linear with respect to amphethinile
concentration up to equivalence in molar concentration for
drug and protein. From the break in this curve it may be
deduced that there is one strong binding site per tubulin. At
higher amphethinile concentrations there is a continued
increase in quenching activity. This is again linear with
respect to increasing amphethinile concentration but is much
more gradual than that observed for lower concentrations of
amphethinile (up to 1 amphethinile/tubulin). Both portions
of the curve show excellent correlation coefficients when
analysed by linear regression (0.99). The origin of this
second linear decrease in fluorescence is not known but may
arise from the binding of drugs to other sites on the tubulin
molecule. Hence from these data it may be deduced that
there is one strong binding site for amphethinile per tubulin
molecule. The association constant calculated from this data
(1.3 x 106M-1, Figure 4) is similar to values reported for
colchicine (1-4 x 106M-1; Hiratsuka & Kato, 1987).
Binding of 3H-colchicine to tubulin can be reduced by co-
incubation with amphethinile (Figure 5). Similar binding
studies using three concentrations of 3H-colchicine (0.5, 1.0
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Figure 2 Effect of amphethinile on assembled tubulin. Assembly
is initiated by rapid heating from 10°C to 35°C. Drug is added
following assembly after 17min as indicated in the figure.
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Figure 1 Effect of amphethinile on tubulin assembly in vitro.
Assembly is initiated by rapid heating to 35°C from 10°C as
indicated in the figure. Disassembly is initiated by rapid cooling to
I0°C.
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Figure 3 The effect of increasing concentrations of amphethinile
on the intrinsic fluorescence of tubulin.
and 2.0gm) result in an inhibition plot indicating
competitive binding between amphethinile and colchicine.
The K; derived for amphethinile (1 gM) was calculated from
a double reciprocal plot of [colchicine]- I free against
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Figure 4 Estimation of the association constant of amphethinile
with tubulin. The association constant (Ka) is calculated from the
gradient of the graph of B/(l -B) against the concentration of
free amphethinile according to the equations
B 1
Ka=( -B)U [L]f
where B=(Ft-FIp)/(F1p1-Flp) and [L]f=[L]-B[C], Fl, Flp, and
Flpl are relative fluorescences of the mixture, the unliganded
protein, and the fully liganded protein respectively. The con-
centrations of ligand binding sites, the unliganded protein, and
the fully liganded protein are C, [L]f and [L] respectively
(Prakash & Timasheff, 1983).
[colchicine]- . No statistically valid alteration in the binding
of 3H-vinblastine was observed under similar experimental
conditions. Hence it may be deduced that the amphethinile
binding site is the same as or in close proximity to that of
colchicine, and not vinblastine.
Amphethinile can be seen to stimulate GTPase activity in
tubulin (Figure 6) by some 66%. This is greater than the
GTPase stimulation reported for colchicine (17%) under
similar experimental conditions, but less than that observed
for the anti-mitotic agent combretastatin (125%) (Hamel &
Lin, 1983).
Discussion
The vinca alkaloids are among the most widely used anti-
cancer agents. Their mode of action is believed to be
interaction with tubulin and consequent disruption of micro-
tubular function. Microtubules are known to be involved in
many processes including chromosome segregation, cell
shape, motility and secretory activity.
The novel synthetic agent amphethinile has been shown to
cause a G2/M phase block in the cell cycle (McGown et al.,
1984). These results show that amphethinile binds strongly to
microtubule protein (K. 1.3 x 106M-1). This interaction has
been shown to be capable of inhibiting tubulin assembly, but
shows no rapid stimulation of disassembly when added to
assembled tubulin. The concentration of amphethinile
required to inhibit assembly by 50% (12 M) is very similar
to that for colchicine (11 uM).
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Figure 5 Effect of amphethinile on the binding of 3H-colchicine
on tubulin. All values are relative to colchicine binding in the
absence of added amphethinile (100%). Error bars represent the
standard error of the means of replicate experiments.
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Figure 6 Effect of amphethinile on the GTPase activity of
tubulin. The GTPase activity is expressed as the concentration of
GDP formed.
Amphethinile has been shown to be capable of competing
for colchicine binding sites but not for those of the vinca
alkaloids. The stoichiometry of binding (1 drug/tubulin)
compares well with that reported for colchicine (Hiratsuka &
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Kato, 1987). Amphethinile can also be shown to stimulate
the GTPase activity of tubulin in a manner similar to that
observed for combretastatin A4 and 2-methoxy-5-(2',3',4'-tri-
methoxyphenyl) tropolone (MTPT). These agents have been
reported to share the colchicine binding site on tubulin
(Hamel & Lin, 1983). These effects occur at concentrations
below those observed in the serum of mice following
amphethinile treatment (McGown et al., 1988).
In conclusion the novel agent amphethinile shows a
remarkable similarity to colchicine in terms of its binding to
tubulin and inhibition of microtubular assembly in vitro.
This work was supported by the Cancer Research Campaign.
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